In human corneal epithelial T cells, pretreatment with recombinant Tbeta(4) dramatically reduced cell death induced by FasL.
In plain wordsIn cells, thymosin beta‑4 pretreatment greatly reduced death of human corneal cells caused by FasL.
- Peptide
- Thymosin beta-4 (human)
- Outcome
- DecreaseFasL-induced HCE-T cell death
- Study
humann: not reported in source
SV40-immortalized human corneal epithelial T (HCE-T) cells- Comparator
- Cells without Tbeta(4)
- Outcome group
- Neuroprotection · Eye
- Studied dose
- Dose not stated
Source sentences
The death of HCE-T cells induced by both FasL and H(2)O(2) was dramatically reduced by the recombinant Tbeta(4) pretreatment.
1 context sentence(design, population, supporting numbers)
HCE-T cells were incubated without or with the recombinant histidine-tagged Tbeta(4) produced by Escherichia coli before the addition of FasL or H(2)O(2).